🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the service has removed problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

After minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to potentially serious medical dangers”.